ImmunoBiome
About:
ImmunoBiome is a biotech company developing microbiome therapeutics to treat incurable diseases like autoimmune diseases.
Website: https://en.immunobiome.co.kr/
Top Investors: KOREA INVESTMENT & SECURITIES, DSC Investment, Korea Investment Partners, Company K Partners, Aju IB Investment
Description:
ImmunoBiome aims to develop microbiome therapeutics to treat incurable diseases like cancer and autoimmune diseases based on our top-notch immunology, bioinformatics, and microbiome-oriented basic research.
Total Funding Amount:
$27.2M
Headquarters Location:
Pohang, Kyongsang-bukto, South Korea
Founded Date:
2019-06-20
Contact Email:
dhlee(AT)immunobiome.co.kr
Founders:
Sin-Hyeog Im
Number of Employees:
11-50
Last Funding Date:
2021-09-23
IPO Status:
Private
Industries:
© 2025 bioDAO.ai